An A1C of 8.7 percent corresponds to an estimated average glucose of about 202 mg/dL — well above the standard American Diabetes Association adult target of below 7 percent. At this level, most clinicians will discuss either a multi-drug regimen or, for people with type 1 diabetes and many with type 2 diabetes not yet on insulin, starting basal insulin. The number is not an emergency, but it is the kind of sustained reading that materially raises complication risk over years.
What A1C 8.7 Percent Means
A1C 8.7 sits 1.7 percentage points above the standard adult target. The American Diabetes Association explicitly recommends intensifying therapy when a person is not at their individualized target despite consistent effort. At 8.7 percent:
- Average glucose is roughly 50 mg/dL higher than at A1C 7.0
- Post-meal peaks regularly exceed 250 mg/dL
- Symptoms of hyperglycemia (increased thirst, urination, fatigue) become more common
- Long-term microvascular complication risk is meaningfully higher than at 7 to 7.5 percent
A1C 8.7 in the Broader Range
| A1C (%) | Classification | eAG (mg/dL) |
|---|---|---|
| Below 5.7 | Normal | Below 117 |
| 5.7 to 6.4 | Prediabetes | 117 to 137 |
| 6.5 to 6.9 | Diabetes — tight control | 140 to 151 |
| 7.0 to 7.9 | Diabetes — at or near target | 154 to 180 |
| 8.0 to 8.4 | Diabetes — above target | 183 to 194 |
| 8.5 to 8.9 | Diabetes — poor control, multi-drug or insulin often warranted | 197 to 209 |
| 9.0 to 9.9 | Diabetes — very poor control | 212 to 237 |
| 10.0 or higher | Diabetes — severe | 240 or higher |
A1C to Average Glucose Conversion
| A1C (%) | eAG (mg/dL) | eAG (mmol/L) |
|---|---|---|
| 7.0 | 154 | 8.6 |
| 8.0 | 183 | 10.2 |
| 8.2 | 189 | 10.5 |
| 8.5 | 197 | 11.0 |
| 8.7 | 202 | 11.3 |
| 9.0 | 212 | 11.8 |
| 9.5 | 226 | 12.6 |
| 10.0 | 240 | 13.4 |
Why A1C 8.7 Often Prompts Multi-Drug or Insulin Discussion
ADA Standards of Care recommend that if A1C is more than 1.5 to 2 percentage points above an individual’s target despite first-line therapy, clinicians should consider:
- Adding a GLP-1 receptor agonist (semaglutide, tirzepatide, liraglutide) — typically lowers A1C by 1 to 1.8 percent
- Adding an SGLT2 inhibitor (empagliflozin, dapagliflozin) — typically lowers A1C by 0.5 to 1 percent with cardiovascular and kidney benefits
- Adding basal insulin (glargine, degludec) — most reliable lowering, typically 1 to 2 percent reduction
- For some, dual therapy combining a GLP-1 receptor agonist and basal insulin
The right combination depends on weight, kidney function, cardiovascular history, cost, and personal preference.
What to Do Next at A1C 8.7
- Schedule a focused visit. Bring a glucose log or continuous glucose monitor data from the past 2 to 4 weeks.
- Discuss medication intensification. Most people at 8.7 will leave with a medication change.
- Identify the dominant glucose problem. Is your fasting glucose high (basal insulin or long-acting agents help most), or are post-meal peaks the issue (GLP-1 agonists, rapid-acting insulin, or dietary changes help most)?
- Tighten the nutrition plan. Reduce refined carbohydrate intake, particularly sugary drinks, white rice, white bread, and large juice portions. Aim for plate-method or carb counting with a registered dietitian.
- Build in activity. 150 minutes per week of moderate activity plus 2 resistance sessions improves insulin sensitivity within weeks.
- Address sleep and stress. Poor sleep and chronic stress raise cortisol and glucose.
- Recheck A1C in 3 months to confirm the plan is working.
Complication Risk at A1C 8.7
UKPDS data show each 1 percentage point reduction in A1C in type 2 diabetes is associated with roughly:
- 35 percent lower risk of microvascular complications
- 14 to 16 percent lower risk of myocardial infarction
- 21 percent lower risk of diabetes-related mortality
Moving from 8.7 to 7.0 — a reduction of 1.7 percentage points — is well within range of standard treatment intensification and meaningfully reduces long-term risk.
Adjacent A1C Values
- Versus A1C 8.2: Slightly lower; multi-drug less urgent — see A1C 8.2.
- Versus A1C 9.5: Higher; insulin strongly considered — see A1C 9.5.
- Glucose equivalent: Average around 202 mg/dL — compare with blood sugar 240, a common post-meal peak at this A1C.
Related Reading
See our broader guides on A1C levels, diabetes treatment, and diabetes complications.
The Bottom Line
An A1C of 8.7 percent reflects an average glucose around 202 mg/dL — well above target and a signal for either a multi-drug regimen or basal insulin in most adults. It is not an emergency, but sustained values at this level materially raise long-term complication risk. The combination of newer agents (GLP-1 receptor agonists, SGLT2 inhibitors) with structured nutrition and activity routinely brings A1C below 7.5 within 3 to 6 months. Schedule a visit, bring your data, and build a 3-month plan.
